Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 299

1.

Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.

Warnke C, Stettner M, Lehmensiek V, Dehmel T, Mausberg AK, von Geldern G, Gold R, Kümpfel T, Hohlfeld R, Mäurer M, Stangel M, Straeten V, Limmroth V, Weber T, Kleinschnitz C, Wattjes MP, Svenningsson A, Olsson T, Hartung HP, Hermsen D, Tumani H, Adams O, Kieseier BC.

Mult Scler. 2014 Nov 12. pii: 1352458514556296. [Epub ahead of print]

PMID:
25392339
[PubMed - as supplied by publisher]
2.

Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia.

Warnke C, Dehmel T, Ramanujam R, Holmen C, Nordin N, Wolfram K, Leussink VI, Hartung HP, Olsson T, Kieseier BC.

Neurology. 2014 Oct 31. pii: 10.1212/WNL.0000000000001049. [Epub ahead of print]

PMID:
25361781
[PubMed - as supplied by publisher]
3.

FoxP3+ regulatory T cells determine disease severity in rodent models of inflammatory neuropathies.

Meyer zu Hörste G, Cordes S, Mausberg AK, Zozulya AL, Wessig C, Sparwasser T, Mathys C, Wiendl H, Hartung HP, Kieseier BC.

PLoS One. 2014 Oct 6;9(10):e108756. doi: 10.1371/journal.pone.0108756. eCollection 2014.

PMID:
25286182
[PubMed - in process]
Free PMC Article
4.

Relevance of CD34+ cells as a reservoir for JC virus in patients with multiple sclerosis.

Warnke C, Adams O, Kieseier B.

JAMA Neurol. 2014 Sep;71(9):1192. doi: 10.1001/jamaneurol.2014.1855. No abstract available.

PMID:
25200545
[PubMed - in process]
5.

Defining the new end point for multiple sclerosis treatment.

Stangel M, Penner IK, Kieseier BC.

JAMA Neurol. 2014 Aug;71(8):1056-7. doi: 10.1001/jamaneurol.2014.1542. No abstract available.

PMID:
25111213
[PubMed - in process]
6.

Thymic epithelium determines a spontaneous chronic neuritis in Icam1(tm1Jcgr)NOD mice.

Meyer zu Horste G, Mausberg AK, Cordes S, El-Haddad H, Partke HJ, Leussink VI, Roden M, Martin S, Steinman L, Hartung HP, Kieseier BC.

J Immunol. 2014 Sep 15;193(6):2678-90. doi: 10.4049/jimmunol.1400367. Epub 2014 Aug 8.

PMID:
25108020
[PubMed - in process]
7.

Defining a role for laquinimod in multiple sclerosis.

Kieseier BC.

Ther Adv Neurol Disord. 2014 Jul;7(4):195-205. doi: 10.1177/1756285614529615. Review.

PMID:
25002907
[PubMed]
Free PMC Article
8.

IVIG regulates BAFF expression in patients with chronic inflammatory demyelinating polyneuropathy (CIDP).

Ritter C, Förster D, Albrecht P, Hartung HP, Kieseier BC, Lehmann HC.

J Neuroimmunol. 2014 Sep 15;274(1-2):225-9. doi: 10.1016/j.jneuroim.2014.06.007. Epub 2014 Jun 19.

PMID:
25002077
[PubMed - indexed for MEDLINE]
9.

Bacteria and their cell wall components uniformly co-activate interleukin-17-producing thymocytes.

Weber A, Zimmermann C, Kieseier BC, Hartung HP, Hofstetter HH.

Clin Exp Immunol. 2014 Dec;178(3):504-15. doi: 10.1111/cei.12414.

PMID:
24995465
[PubMed - in process]
10.

CD19 as a molecular target in CNS autoimmunity.

Stüve O, Warnke C, Deason K, Stangel M, Kieseier BC, Hartung HP, von Büdingen HC, Centonze D, Forsthuber TG, Knappertz V.

Acta Neuropathol. 2014 Aug;128(2):177-90. doi: 10.1007/s00401-014-1313-z. Epub 2014 Jul 4.

PMID:
24993505
[PubMed - in process]
11.

Alemtuzumab: the advantages and challenges of a novel therapy in MS.

Menge T, Stüve O, Kieseier BC, Hartung HP.

Neurology. 2014 Jul 1;83(1):87-97. doi: 10.1212/WNL.0000000000000540. Epub 2014 Jun 11. Review.

PMID:
24920854
[PubMed - indexed for MEDLINE]
12.

Defining the clinical course of multiple sclerosis: the 2013 revisions.

Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH.

Neurology. 2014 Jul 15;83(3):278-86. doi: 10.1212/WNL.0000000000000560. Epub 2014 May 28.

PMID:
24871874
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

A role of peripheral myelin protein 2 in lipid homeostasis of myelinating Schwann cells.

Zenker J, Stettner M, Ruskamo S, Domènech-Estévez E, Baloui H, Médard JJ, Verheijen MH, Brouwers JF, Kursula P, Kieseier BC, Chrast R.

Glia. 2014 Sep;62(9):1502-12. doi: 10.1002/glia.22696. Epub 2014 May 21.

PMID:
24849898
[PubMed - in process]
14.

Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.

Calabresi PA, Kieseier BC, Arnold DL, Balcer LJ, Boyko A, Pelletier J, Liu S, Zhu Y, Seddighzadeh A, Hung S, Deykin A; ADVANCE Study Investigators.

Lancet Neurol. 2014 Jul;13(7):657-65. doi: 10.1016/S1474-4422(14)70068-7. Epub 2014 Apr 30.

PMID:
24794721
[PubMed - indexed for MEDLINE]
15.

The new therapeutic landscape in multiple sclerosis: exciting times and new perspectives.

Hartung HP, Kieseier BC.

Curr Opin Neurol. 2014 Jun;27(3):243-5. doi: 10.1097/WCO.0000000000000101. No abstract available.

PMID:
24751962
[PubMed - in process]
16.

Cerebrospinal Fluid JC Virus Antibody Index for Diagnosis of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.

Warnke C, von Geldern G, Markwerth P, Dehmel T, Hoepner R, Gold R, Pawlita M, Kümpfel T, Mäurer M, Stangel M, Wegner F, Hohlfeld R, Straeten V, Limmroth V, Weber T, Hermsen D, Kleinschnitz C, Hartung HP, Wattjes MP, Svenningson A, Major E, Olsson T, Kieseier BC, Adams O.

Ann Neurol. 2014 Apr 11. doi: 10.1002/ana.24153. [Epub ahead of print]

PMID:
24729444
[PubMed - as supplied by publisher]
17.

[Multiple erythema migrans and facial nerve paralysis: clinical manifestations of early disseminated Lyme borreliosis].

Braun SA, Baran AM, Boettcher C, Kieseier BC, Reifenberger J.

Hautarzt. 2014 Apr;65(4):268-71. doi: 10.1007/s00105-014-2782-7. German.

PMID:
24700023
[PubMed - in process]
18.

Interleukin-17 impedes Schwann cell-mediated myelination.

Stettner M, Lohmann B, Wolffram K, Weinberger JP, Dehmel T, Hartung HP, Mausberg AK, Kieseier BC.

J Neuroinflammation. 2014 Mar 29;11:63. doi: 10.1186/1742-2094-11-63.

PMID:
24678820
[PubMed - in process]
Free PMC Article
19.

Treating neuromyelitis optica with the interleukin-6 receptor antagonist tocilizumab.

Lauenstein AS, Stettner M, Kieseier BC, Lensch E.

BMJ Case Rep. 2014 Mar 26;2014. pii: bcr2013202939. doi: 10.1136/bcr-2013-202939.

PMID:
24671322
[PubMed - in process]
20.

Sural sparing pattern discriminates Guillain-Barré syndrome from its mimics.

Derksen A, Ritter C, Athar P, Kieseier BC, Mancias P, Hartung HP, Sheikh KA, Lehmann HC.

Muscle Nerve. 2014 Nov;50(5):780-4. doi: 10.1002/mus.24226. Epub 2014 Sep 24.

PMID:
24616124
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk